Fei Zhou

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Fengying Wu, Jue Fan, Yayi He et al. · Nature Communications · 2021 · 803 citations · Full text

Medicine, Cancer Biology, Oncology +15

Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

Xiaomei Gong, Xuefei Li, Tao Jiang et al. · Journal of Thoracic Oncology · 2017 · 301 citations

Medicine, Oncology, Radiation Oncology +10

Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs

Qinghua Xu, Fei Zhou, Hui Liu et al. · Journal of Thoracic Oncology · 2018 · 198 citations

Medicine, Oncology, Pharmacotherapy +11

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases

Tao Jiang, Chunxia Su, Xuefei Li et al. · Journal of Thoracic Oncology · 2016 · 149 citations · Full text

Medicine, Oncology, Immunotherapy +10

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy

Haixia Long, Qingzhu Jia, Liuyang Wang et al. · Cancer Cell · 2022 · 142 citations

Medicine, Immunology, Oncology +12